Literature DB >> 27725873

Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.

Lei Sun1, Peng Sun2, Qi-Ying Zhou3, Xiangchun Gao1, Qing Han1.   

Abstract

Increasing evidences have demonstrated that long noncoding RNAs (LncRNAs) play a significant role in the development of tumor. However, the role of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in uveal melanoma remains unknown. In this study, we demonstrated that the expression of MALAT1 was upregulated in the uveal melanoma tissues compared to normal tissues. Among them, MALAT1 was upregulated in 72% (18/25) uveal melanoma tissues compared to their paired normal tissues. Knockdown of MALAT1 suppressed uveal melanoma cell proliferation, colony information, invasion and migration. Moreover, we showed that knockdown of MALAT1 promoted miR-140 expression and suppressed Slug and ADAM10 expression in the MUM-2C cell. In addition, we demonstrated that miR-140 was downregulated in the uveal melanoma tissues compared to normal tissues and cell lines. The expression level of MALAT1 was inversely correlated with the expression level of miR-140 in uveal melanoma tissues. These results suggested that MALAT1 served as an oncogenic LncRNA in the development of uveal melanoma.

Entities:  

Keywords:  LncRNAs; Long noncoding RNA; MALAT1; mir-140; uveal melanoma

Year:  2016        PMID: 27725873      PMCID: PMC5040691     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  42 in total

1.  The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma.

Authors:  Chuan Jin; Bingchuan Yan; Qin Lu; Yanmin Lin; Lei Ma
Journal:  Tumour Biol       Date:  2015-10-20

Review 2.  Latest developments in the biology and management of uveal melanoma.

Authors:  Sapna P Patel
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

3.  miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA.

Authors:  Hong Lan; Wangsheng Chen; Guoli He; Shuying Yang
Journal:  Biomed Pharmacother       Date:  2015-08-18       Impact factor: 6.529

Review 4.  Transhepatic therapies for metastatic uveal melanoma.

Authors:  David J Eschelman; Carin F Gonsalves; Takami Sato
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

5.  MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer.

Authors:  Wei Dong; Chunping Yao; Xuepeng Teng; Jie Chai; Xinhua Yang; Baosheng Li
Journal:  Tumour Biol       Date:  2015-09-28

6.  Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2.

Authors:  Ming-de Huang; Wen-ming Chen; Fu-zhen Qi; Rui Xia; Ming Sun; Tong-peng Xu; Li Yin; Er-bao Zhang; Wei De; Yong-qian Shu
Journal:  J Hematol Oncol       Date:  2015-05-14       Impact factor: 17.388

Review 7.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

Review 8.  Current and emerging treatment options for uveal melanoma.

Authors:  Patricia Rusa Pereira; Alexandre Nakao Odashiro; Li-Anne Lim; Cristina Miyamoto; Paula L Blanco; Macanori Odashiro; Shawn Maloney; Dominique F De Souza; Miguel N Burnier
Journal:  Clin Ophthalmol       Date:  2013-08-22

9.  Low expression of LOC285194 is associated with poor prognosis in colorectal cancer.

Authors:  Peng Qi; Mi-die Xu; Shu-juan Ni; Dan Huang; Ping Wei; Cong Tan; Xiao-yan Zhou; Xiang Du
Journal:  J Transl Med       Date:  2013-05-16       Impact factor: 5.531

10.  Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma.

Authors:  Hirotaka Konishi; Daisuke Ichikawa; Yusuke Yamamoto; Tomohiro Arita; Katsutoshi Shoda; Hidekazu Hiramoto; Junichi Hamada; Hiroshi Itoh; Yuji Fujita; Shuhei Komatsu; Atsushi Shiozaki; Hisashi Ikoma; Toshiya Ochiai; Eigo Otsuji
Journal:  Cancer Sci       Date:  2016-02-09       Impact factor: 6.716

View more
  39 in total

1.  Long non-coding RNA CASC15 promotes tongue squamous carcinoma progression through targeting miR-33a-5p.

Authors:  Zhibin Zuo; Long Ma; Zuode Gong; Lande Xue; Qibao Wang
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-26       Impact factor: 4.223

2.  Suppression of long noncoding RNA MALAT1 inhibits the development of uveal melanoma via microRNA-608-mediated inhibition of HOXC4.

Authors:  Shuai Wu; Han Chen; Ling Zuo; Hai Jiang; Hongtao Yan
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

Review 3.  The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer.

Authors:  Jichuan Xu; Jian Xu; Xinyuan Liu; Jianxin Jiang
Journal:  Cell Death Discov       Date:  2022-06-14

4.  A novel 7‑hypoxia‑related long non‑coding RNA signature associated with prognosis and proliferation in melanoma.

Authors:  Yi Luo; Tinghao Li; Hengguang Zhao; Aijun Chen
Journal:  Mol Med Rep       Date:  2022-06-15       Impact factor: 3.423

Review 5.  Long non-coding RNAs in melanoma.

Authors:  Xin Yu; Heyi Zheng; Gary Tse; Matthew Tv Chan; William Kk Wu
Journal:  Cell Prolif       Date:  2018-03-26       Impact factor: 6.831

6.  The long non-coding RNA CRNDE competed endogenously with miR-205 to promote proliferation and metastasis of melanoma cells by targeting CCL18.

Authors:  Libin Xu; Yu Zhang; Zhenguo Zhao; Zhengju Chen; Zheng Wang; Songfeng Xu; Xinxin Zhang; Ting Liu; Shengji Yu
Journal:  Cell Cycle       Date:  2018-10-09       Impact factor: 4.534

7.  Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a.

Authors:  Zhiwen Ba; Lili Gu; Songnan Hao; Xiaofang Wang; Zhenping Cheng; Guangchen Nie
Journal:  Cell Prolif       Date:  2017-11-30       Impact factor: 6.831

8.  Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma.

Authors:  Qingbo Li; Xiaohan Pan; Xiqian Wang; Xiejia Jiao; Jiachun Zheng; Zhiqiang Li; Yanqing Huo
Journal:  Oncotarget       Date:  2017-09-06

9.  Global network random walk for predicting potential human lncRNA-disease associations.

Authors:  Changlong Gu; Bo Liao; Xiaoying Li; Lijun Cai; Zejun Li; Keqin Li; Jialiang Yang
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

Review 10.  LncRNAs regulate cancer metastasis via binding to functional proteins.

Authors:  Liting Yang; Yanyan Tang; Fang Xiong; Yi He; Fang Wei; Shanshan Zhang; Can Guo; Bo Xiang; Ming Zhou; Ni Xie; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong; Zhaoyang Zeng
Journal:  Oncotarget       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.